Regimen-related toxicity after fludarabine–melphalan conditioning: a prospective study of 31 patients with hematologic malignancies
Open Access
- 27 August 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (5) , 471-476
- https://doi.org/10.1038/sj.bmt.1704166
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplantBone Marrow Transplantation, 2001
- Acute left ventricular failure following melphalan and fludarabine conditioningBone Marrow Transplantation, 2001
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationBone Marrow Transplantation, 1999
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- High-dose intravenous melphalan: a review.Journal of Clinical Oncology, 1995
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- CYCLOSPORIN INTERACTION WITH KETOCONAZOLE AND MELPHALANThe Lancet, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958